Navigation Links
Argos Therapeutics to Present Potential of its Arcelis™ Immunotherapy as an Innovative, Effective Treatment for HIV at the APHA 138th Annual Meeting & Exposition
Date:11/9/2010

DURHAM, N.C., Nov. 9, 2010 /PRNewswire/ -- Argos Therapeutics today announced that Jeff Abbey, the company's president and chief executive officer, will present on the potential of Argos' Arcelis™ immunotherapy as an innovative and effective treatment for HIV at the APHA 138th Annual Meeting & Exposition in Denver, Colo., at 1:45 p.m. MST on Wednesday, Nov. 10. The conference will take place at the Colorado Convention Center.

Data from a Phase 2a trial of Argos' Arcelis HIV program, AGS-004, demonstrated a significant reduction in viral load and a delay in viral rebound kinetics during a 12-week antiretroviral treatment interruption (ARTI) when compared to pre-ART viral loads. AGS-004 is currently being tested in a double-blind, placebo controlled, randomized Phase 2b study co-funded by the NIH to further demonstrate that it is a feasible treatment option of HIV-1 infected patients.

About the Arcelis™ Technology

Arcelis is Argos' proprietary technology for personalizing RNA-loaded dendritic cell immunotherapies for cancer, HIV and other infectious diseases. This platform is based on optimizing a patient's own (autologous) dendritic cells to trigger a tumor- or pathogen-specific immune response. To address the challenge of the unique genetic profile of each patient's disease and the genetic mutations of that disease, Argos loads the autologous dendritic cells with a sample of messenger RNA ("mRNA") isolated from the patient's disease. Through this process, dendritic cells can potentially prime immune responses to the entire antigenic repertoire, resulting in an immunotherapeutic that is customized to the patient's specific disease.

About Argo
'/>"/>

SOURCE Argos Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Argos Therapeutics to Present Overview of its Arcelis™ Dendritic Cell-based Immunotherapy, Participate in Panel Discussion at Inaugural Cancer Immunotherapy Conference
2. Argos Therapeutics to Present Recent Clinical Developments and Corporate Overview at 18th Annual BioPartnering Europe
3. Results From Argos Therapeutics Arcelis™ Immunotherapy Phase 2 Study for Treatment of Renal Cell Carcinoma (RCC) Accepted for Poster Presentation at Ninth International Kidney Cancer Symposium
4. Amicus Therapeutics Announces Third Quarter 2010 Financial Results
5. Mederi Therapeutics Announces Receipt of CE Mark for its Second Generation Secca® and Stretta® Systems
6. Pervasis Therapeutics Awarded Four Grants Under the Qualifying Therapeutic Discovery Project
7. Nektar Therapeutics Reports Third Quarter 2010 Financial Results
8. Orexigen® Therapeutics Reports Third Quarter 2010 Financial Results
9. Karyopharm Therapeutics Inc. Closes $20 Million Series A Financing to Advance Pipeline of Novel Nuclear Transport Modulators for Cancer, Inflammation and Other Disorders
10. Talecris Biotherapeutics Launches PROLASTIN®-C in Canada
11. Cell Therapeutics Awarded $977,917 in Grants Under the Therapeutic Discovery Tax Credit Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... DUBLIN , Apr. 16, 2015 Research and ... addition of the "Corporate Reputation of Pharma in ... - 1st Edition" report to their offering. ... has compared opinions on the corporate reputation of the ... in mental health with the views of patient organisations ...
(Date:4/17/2015)... , April 17, 2015 Bionomics Limited ... and development of innovative therapeutics for the treatment of ... announced the presentation of data from three of its ... for Cancer Research (AACR) 106 th Annual Meeting ... Philadelphia, PA USA. The ...
(Date:4/16/2015)... Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ... commercialization of products for the treatment of central nervous ... the first quarter of 2015 on Wednesday, May 6, ... Company will host a conference call at 4:30 PM ... management will discuss the first quarter 2015 financial results ...
Breaking Medicine Technology:Corporate Reputation of Pharma in 2014 - The Perspective of Mental Health Patient Groups - 1st Edition 2Corporate Reputation of Pharma in 2014 - The Perspective of Mental Health Patient Groups - 1st Edition 3Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 2Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 3Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 4Bionomics Showcases Oncology Drug Development Programs at 2015 AACR Annual Meeting 5Vanda Pharmaceuticals to Announce First Quarter 2015 Financial Results on May 6, 2015 2
... 2011 Life Technologies Corporation (Nasdaq: ... semiconductor sequencing chip will be available for early access ... and analysis software, providing up to 1Gb of data ... 314 chip introduced two months ago with the ...
... Omnicell, Inc ., (Nasdaq: OMCL ... healthcare facilities, today announced the results of a survey ... to identify trends in requirements for vendor interoperability and ... that the majority of hospitals recognize the critical role ...
Cached Medicine Technology:Life Technologies to Launch Ion 318 Chip in Second Half of 2011 with 1Gb of Data Output 2Life Technologies to Launch Ion 318 Chip in Second Half of 2011 with 1Gb of Data Output 3Life Technologies to Launch Ion 318 Chip in Second Half of 2011 with 1Gb of Data Output 475 Percent of Hospital IT Leaders View Interoperability Between Vendor Systems as Critical to Operational Effectiveness in Healthcare Settings 2
(Date:4/17/2015)... 2015 John Evans, a Gardant affordable ... Patio from 2 p.m. to 3 p.m. on April ... Executive Ct. in Pekin, Illinois, serves older adults of ... help to maintain their independence. , Becky Baker will ... will be served during the luau. , For more ...
(Date:4/17/2015)... Beach, California (PRWEB) April 17, 2015 ... surgeon Dr. Kevin Sadati of the Gallery ... of Orange County’s top beauty experts. The publication ... neck lift, facial stem cell fat grafting, eyelid surgery, ... to facial plastic surgery has resulted in ...
(Date:4/17/2015)... (PRWEB) April 17, 2015 “We have seen ... of the past and present,” said Chaplain Shawn Kafader of ... hadn’t felt like they had anything to contribute have created ... has overseen a new art therapy program that was launched ... a Masters student from School of the Art Institute in ...
(Date:4/17/2015)... CA (PRWEB) April 17, 2015 Consumers ... insurance protection without modifications can now use the Insurance ... general life insurance policy rates that are featured by ... The standard plans that are offered are mixed between ... aged 18 to 79. There are now term, universal ...
(Date:4/17/2015)... As a board-certified orthopedic surgeon, Dr. ... of platelet-rich plasma (PRP) and stem cell ... known for its world-class care of injury-caused and chronic ... lacking in many other physicians offering regenerative medicines. ... for pain management and rehabilitation. Dr. Meier and MOSM ...
Breaking Medicine News(10 mins):Health News:John Evans Supportive Living Community Prepares for Party on the Patio 2Health News:Orange County Facial Plastic Surgeon Featured in Premier Magazine Focused on Beauty 2Health News:Orange County Facial Plastic Surgeon Featured in Premier Magazine Focused on Beauty 3Health News:Healing At Friendship Village Due To Art Therapy 2Health News:General Life Insurance Policy Rates Added to Quotation System at Insurance Website Online 2Health News:Platelet-Rich Plasma, Stem Cell Therapy Now Offered By Dr. Meier At MOSM in Beverly Hills, California 2Health News:Platelet-Rich Plasma, Stem Cell Therapy Now Offered By Dr. Meier At MOSM in Beverly Hills, California 3
... More than 250 experts have got together for a conference ... the curtain raiser, of what is going to be a ... Forum was instituted in 2005 by the parliament's corporate body ... channels of communication between politicians, academics and international organizations. ...
... the common cause of amnesia, also prevents victims from thinking ... present. ,Researchers, reporting their study in Tuesday's ... the Wellcome Trust Centre for Neuroimaging, University College London, examined ... that is crucial in learning and memory. ...
... a research they will back all the way through. , ... with the aim of getting the recipient pregnant. // ,The ... difficulties though. ,The wombs would come from dead donors, ... the recipient gives birth so she would not need anti-rejection drugs ...
... Australia health providers is busy counting its losses. ... doctors resort to rorting or over servicing, //by prescribing ... ,The loss in figure s caused by over billing ... body releases its 'Report to the Professions', which looks ...
... be best for your health. A new study found that ... to the bacterium Helicobacter pylori, //and younger siblings from large ... type of stomach cancer. ,These latest findings are ... who were followed over a 28-year period. The researchers found ...
... linked a structural protein called nestin to a particularly ... that could lead to earlier detection and better treatment.// ... Research, researchers from Dartmouth Medical School demonstrate that nestin ... breast tumors, a highly aggressive cancer with similarities to ...
Cached Medicine News:Health News:Amnesia Halts Future Thinking: Study 2Health News:Uterus Transplant- A Future Reality 2Health News:Link Between Family Size and Stomach Cancer Found 2Health News:Link Between Family Size and Stomach Cancer Found 3Health News:Selective Marker Found to Indicate Aggressive Form of Breast Cancer 2Health News:Selective Marker Found to Indicate Aggressive Form of Breast Cancer 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: